Rivaroxaban for Antiphospholipid Antibody Syndrome
Clinical trial NCT02116036 · COMPLETED
Trial details
- NCT number
- NCT02116036
- Sponsor
- St. Joseph's Healthcare Hamilton
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2017-09-30
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.